Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

AMGN

AMGEN Inc

Jan 22 • 04:00PM ET

347.07

+3.47 1.01 %

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD IVV SPY DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	26.83	EPS (ttm)	12.94	Insider Own	0.19%	Shs Outstand	538.50M	Perf Week	5.50%
Market Cap	186.89B	Forward P/E	15.75	EPS next Y	22.04	Insider Trans	-1.18%	Shs Float	537.46M	Perf Month	6.01%
Enterprise Value	232.03B	PEG	3.18	EPS next Q	4.72	Inst Own	81.21%	Short Float	2.79%	Perf Quarter	15.25%
Income	7.00B	P/S	5.21	EPS this Y	7.31%	Inst Trans	-0.70%	Short Ratio	5.33	Perf Half Y	12.24%
Sales	35.89B	P/B	19.43	EPS next Y	3.53%	ROA	7.74%	Short Interest	14.98M	Perf YTD	6.04%
Book/sh	17.86	P/C	19.79	EPS next 5Y	4.95%	ROE	81.71%	52W High	346.38 0.20%	Perf Year	26.29%
Cash/sh	17.54	P/FCF	16.20	EPS past 3/5Y	-9.75% -10.10%	ROIC	11.29%	52W Low	261.43 32.76%	Perf 3Y	28.82%
Dividend Est.	9.64 (2.78%)	EV/EBITDA	14.80	Sales past 3/5Y	8.54% 7.40%	Gross Margin	70.47%	Volatility	2.77% 2.20%	Perf 5Y	43.62%
Dividend TTM	9.52 (2.74%)	EV/Sales	6.47	EPS Y/Y TTM	65.22%	Oper. Margin	28.56%	ATR (14)	7.85	Perf 10Y	138.60%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	0.99	Sales Y/Y TTM	11.03%	Profit Margin	19.52%	RSI (14)	65.48	Recom	2.24
Dividend Gr. 3/5Y	8.53% 9.18%	Current Ratio	1.28	EPS Q/Q	13.64%	SMA20	4.83%	Beta	0.46	Target Price	336.96
Payout	119.05%	Debt/Eq	5.67	Sales Q/Q	13.32%	SMA50	4.55%	Rel Volume	1.08	Prev Close	343.60
Employees	28000	LT Debt/Eq	5.45	Earnings	Feb 03 AMC	SMA200	15.99%	Avg Volume	2.81M	Price	347.07
IPO	Jun 17, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.37% 6.59%	Trades		Volume	3,024,314	Change	1.01%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-20-26	Downgrade	Bernstein	Outperform → Mkt Perform	$335
Jan-07-26	Resumed	UBS	Buy	$380
Dec-05-25	Upgrade	Erste Group	Hold → Buy
Nov-24-25	Resumed	Truist	Hold	$318
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$385
Sep-03-25	Resumed	Raymond James	Mkt Perform
May-20-25	Resumed	Guggenheim	Neutral	$288
Apr-22-25	Resumed	Cantor Fitzgerald	Neutral	$305
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320

Show Previous Ratings

Jan-22-26 06:00PM	Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know (Zacks)
11:01AM	Stock Market Today: Dow Up On GDP; Amgen Jumps To New Highs, As Abbott Gets Crushed (Live Coverage) (Investor's Business Daily)
09:26AM	Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y (Zacks)
Jan-21-26 02:36PM	Stock Market Today: S&P 500 Higher After Trump Davos News; Johnson & Johnson Slides (Live Coverage) (Investor's Business Daily)
01:04PM	UPS to build massive $6.1M cooler in Louisville. Here's what we know (The Courier Journal)
10:28AM	Loading…
10:28AM	J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales (Zacks)
07:11AM	Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies (Insider Monkey)
Jan-20-26 11:34AM	Nonprofit Health Services Organization Files Lawsuit Against Fortune 500 Pharmaceutical Company Over Prescription Drug Access (Business Wire)
Jan-19-26 03:23PM	Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All (MarketBeat)
02:18PM	2 Dividend Stocks to Buy and Hold For 10 Years (Motley Fool)
09:07AM	Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Results? (Zacks)
08:01AM	Beat the Market the Zacks Way: Amicus, Micron, Amgen in Focus (Zacks)
Jan-16-26 03:55PM	Ahead of the Quantinuum IPO, Should You Buy Honeywell Stock? (Barchart)
Jan-15-26 04:40PM	Amgen's Weight-Loss Drug Shows Promise With Less Frequent Dosing (Barrons.com)
01:52PM	Amgen Inc. (AMGN): A Bull Case Theory (Insider Monkey)
05:50PM	Loading…
Jan-14-26 05:50PM	Amgen (AMGN) Advances While Market Declines: Some Information for Investors (Zacks)
12:36PM	Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses (Benzinga)
08:41AM	Quantum Computing Stocks: Honeywell's Quantinuum Plans IPO (Investor's Business Daily)
Jan-13-26 08:14PM	Amgen CEO: There are a bunch of ways to win for patients when it comes to weight loss (CNBC TV)
08:14PM	Amgen CEO Bob Bradway goes one-on-one with Jim Cramer (CNBC TV)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jan-12-26 11:37PM	1 Healthcare Stock to Keep an Eye On and 2 We Ignore (StockStory)
08:05PM	Amgen Calls 2026 a Springboard Year as CEO Flags Major Data, MariTide Phase 3 Push at JPM Event (MarketBeat)
04:21PM	Expect a Busy Year in Obesity Drugs as New Pills Hit the Market (Barrons.com)
09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-09-26 09:13AM	Betting on More Rate Cuts, Boomers Are Buying the 2026 Small Dogs of the Dow (24/7 Wall St.)
07:23AM	J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts (Pharmaceutical Technology)
Jan-08-26 05:50PM	Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
12:11PM	Alveus launches with $160M to advance MariTide-like obesity drug (BioPharma Dive)
09:11AM	RVMD Stock Hits a Record High on Rumored Takeover Interest (Zacks)
08:57AM	Loading…
08:57AM	J&J's Innovative Medicine Segment in Q4: Here's What to Watch (Zacks)
08:57AM	Can These Dividend Stocks Beat the Market Again in 2026? (Motley Fool)
Jan-07-26 05:12PM	Stock Market Today: Dow Slips Back Below 49K; Trump Takes On Defense Firms (Live Coverage) (Investor's Business Daily)
04:01PM	AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
03:45PM	Stock Market Today: Dow Slides After Surprise Jobs Data, Venezuela Oil News; Nvidia Rises (Live Coverage) (Investor's Business Daily)
01:53PM	Stock Market Today: S&P 500 Hovers Highs In Mixed Session; Mobileye Swings After Deal News (Live Coverage) (Investor's Business Daily)
12:53PM	Stock Market Today: Indexes Mixed After Surprise Jobs Data; Bitcoin Play Strategy Climbs (Live Coverage) (Investor's Business Daily)
11:52AM	ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies (Zacks)
11:36AM	Stock Market Today: Dow Falls Amid Surprise Jobs Data, Venezuela Oil News; Netflix Slips (Live Coverage) (Investor's Business Daily)
11:21AM	Stocks Hover Near Record Highs on Mixed US Economic News (Barchart)
10:07AM	Stocks Supported by Lower Bond Yields (Barchart)
08:33AM	Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline (Zacks)
07:50AM	Amgen buys Dark Blue Therapeutics in $840m oncology deal (Pharmaceutical Technology)
Jan-06-26 12:07PM	Amgen Agrees to Buy Dark Blue Therapeutics in Up to $840 Million Deal (GuruFocus.com)
09:00AM	AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE (PR Newswire)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
07:01AM	What to Expect From Amgen's Q4 2025 Earnings Report (Barchart)
06:25AM	Zenas stock drops 51% despite lead assets Phase III rare disease win (Clinical Trials Arena)
06:17AM	Amgen buys protein-degrading startup Dark Blue for up to $840M (BioPharma Dive)
Jan-05-26 06:00PM	Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors (Zacks)
04:31PM	Stock Market Today: Dow Surges As Maduro Makes This Plea; This AI Stock Clears An Entry (Live Coverage) (Investor's Business Daily)
04:20PM	Zenas BioPharma, A Top 1% Stock, Quadrupled In 2025. Why It Just Collapsed. (Investor's Business Daily)
02:07PM	Stock Market Today: Dow Up 800 Points As Maduro Makes This Plea; Reddit Tests Entry (Live Coverage) (Investor's Business Daily)
07:52AM	Beat the Market the Zacks Way: LATAM, General Motors, Amgen in Focus (Zacks)
06:26AM	Zenas shares crash after top drug misses expectations in immune disease study (BioPharma Dive)
Jan-04-26 11:37PM	1 S&P 500 Stock with Exciting Potential and 2 We Question (StockStory)
Jan-02-26 08:30AM	Axsome (AXSM) Stock Jumps 22.8%: Will It Continue to Soar? (Zacks)
Dec-31-25 02:41PM	Dogs of the Dow Had a Strong Year. Here Are the 10 Stocks for 2026. (Barrons.com)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-30-25 11:01PM	Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
05:44PM	Strong Results and Pipeline Momentum Power Amgen's (AMGN) 2025 Rally (Insider Monkey)
01:22PM	BMY vs AMGN: Which Biotech Stock Is More Resilient Now? (Zacks)
11:05AM	Can Amgen's MariTide Take on Leaders in the Obesity Space? (Zacks)
Dec-29-25 09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-24-25 10:33AM	Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know (Zacks)
Dec-23-25 10:14AM	Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? (Zacks)
08:48AM	5 Big Drug Stocks That May Continue to Outperform in 2026 (Zacks)
Dec-22-25 05:50PM	Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know (Zacks)
11:33AM	Analyst Report: Amgen Inc. (Morningstar Research)
11:21AM	J&J Stock Trading Above 50- & 200-Day SMA for 6 Months: How to Play (Zacks)
08:27AM	Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals (Zacks)
08:04AM	Beat the Market the Zacks Way: Micron, Credo, Coca Cola in Focus (Zacks)
Dec-19-25 05:40PM	Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump (Investor's Business Daily)
04:46PM	Trump reaches deal with 9 drug companies to lower prices (Yahoo Finance Video)
04:30PM	Nine Drugmakers Strike Deals With Trump, With More to Come (Bloomberg)
04:09PM	More Drugmakers Reach Deals With White House to Lower Prices (The Wall Street Journal)
02:50PM	Nine Big Drugmakers Reach Pricing Deals With White House (The Wall Street Journal)
02:50PM	More Big Drugmakers Reach Pricing Deals With White House (The Wall Street Journal)
02:23PM	AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS (PR Newswire)
Dec-18-25 04:45AM	Takeda says $4B TYK2 drug succeeds in large psoriasis studies (BioPharma Dive)
Dec-17-25 02:16PM	HSBC Turns More Bullish on Amgen (AMGN) into 2026 (Insider Monkey)
09:00AM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
Dec-16-25 02:08PM	Amgen (AMGN) Price Target Trimmed at Morgan Stanley as Policy Risks Ease (Insider Monkey)
12:27PM	Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026? (Motley Fool)
09:17AM	3 Healthcare Giants Just Raised Dividends-Here's Who Pays the Most (MarketBeat)
Dec-15-25 05:50PM	Amgen (AMGN) Rises As Market Takes a Dip: Key Facts (Zacks)
04:26PM	Stock Market Today: Dow Dips Amid Ukraine-Russia Progress; Trump Eyes This Fed Move (Live Coverage) (Investor's Business Daily)
10:10AM	Stock Market Today: Dow Edges Up As Tesla Jumps Near Buy Point, Apple Lags (Live Coverage) (Investor's Business Daily)
Dec-14-25 03:07PM	2 Dividend Stocks to Double Up on Right Now (Motley Fool)
Dec-12-25 08:22AM	Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis (Zacks)
Dec-11-25 06:09PM	FDA APPROVES UPLIZNA FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS (PR Newswire)
Dec-10-25 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Dec-09-25 04:01PM	AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND (PR Newswire)
01:21PM	Stocks Pause Ahead of Fed Decision on Rates (Barrons.com)
12:06PM	Columbuss Reputation as an Affordable City Is Making Its Homes More Expensive (The Wall Street Journal)
05:21AM	Inductive Bio gains $21m ARPA-H funds for drug prediction models (Pharmaceutical Business Review)
Dec-08-25 11:10AM	Can J&J Offset Stelara LOE, MedTech China and Legal Headwinds in 2026? (Zacks)
08:23AM	Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus (Zacks)
Dec-06-25 01:25PM	BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens (Insider Monkey)
Dec-05-25 09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Option Exercise	169.70	3,139	532,691	8,864	Nov 21 08:34 PM
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Sale	337.26	3,139	1,058,667	7,225	Nov 21 08:34 PM
Grygiel Nancy A.	Officer	Nov 20 '25	Proposed Sale	337.26	3,139	1,058,667		Nov 20 04:45 PM
Khosla Rachna	SVP, Business Development	Nov 12 '25	Sale	336.24	890	299,256	7,082	Nov 13 07:29 PM
Gordon Murdo	EVP, Global Commercial Ops	Nov 12 '25	Sale	336.83	6,879	2,317,071	41,923	Nov 13 07:28 PM
Gordon Murdo	Officer	Nov 12 '25	Proposed Sale	337.23	6,879	2,319,805		Nov 12 03:02 PM
Khosla Rachna	Officer	Nov 12 '25	Proposed Sale	337.42	890	300,304		Nov 12 02:50 PM
Grygiel Nancy A.	SVP & CCO	Aug 20 '25	Sale	296.99	1,267	376,280	7,209	Aug 22 07:21 PM
Grygiel Nancy A.	Officer	Aug 20 '25	Proposed Sale	294.32	1,267	372,909		Aug 20 04:31 PM
Khosla Rachna	SVP, Business Development	Jun 05 '25	Sale	289.68	1,500	434,520	8,162	Jun 06 07:49 PM
Khosla Rachna	Officer	Jun 05 '25	Proposed Sale	290.00	1,500	435,000		Jun 05 12:24 PM
Busch Matthew C.	VP, Finance & CAO	May 02 '25	Sale	279.69	1,000	279,690	4,034	May 06 08:07 PM
Busch Matthew C.	Officer	May 02 '25	Proposed Sale	281.44	1,000	281,440		May 02 02:37 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	80,257	Feb 21 08:07 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Sale	292.84	8,711	2,550,903	71,546	Feb 21 08:07 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	70,858	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 21 '25	Sale	304.44	25,225	7,679,524	36,922	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Sale	293.22	8,711	2,554,224	62,147	Feb 21 08:06 PM
DAVID M REESE & JOAN I CHUCO-T	Officer	Feb 21 '25	Proposed Sale	304.44	25,225	7,679,524		Feb 21 04:27 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Option Exercise	156.35	1,524	238,277	10,068	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Sale	293.74	1,524	447,655	8,544	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 18 '25	Sale	292.56	500	146,279	8,544	Feb 20 08:59 PM
DEREK MILLER	Officer	Feb 19 '25	Proposed Sale	293.74	1,524	447,655		Feb 19 04:18 PM
DAVID REESE	Officer	Feb 19 '25	Proposed Sale	293.22	8,711	2,554,224		Feb 19 04:14 PM
Santos Esteban	Affiliate	Feb 19 '25	Proposed Sale	292.11	8,711	2,544,570		Feb 19 02:25 PM
DEREK MILLER	Officer	Feb 18 '25	Proposed Sale	292.56	500	146,279		Feb 18 04:10 PM
Gordon Murdo	EVP, Global Commercial Ops	Feb 11 '25	Sale	294.79	8,771	2,585,644	44,186	Feb 13 09:02 PM
Gordon Murdo	Officer	Feb 11 '25	Proposed Sale	295.30	8,771	2,590,076		Feb 11 03:01 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Option Exercise	156.35	25,045	3,915,786	54,032	Feb 10 09:52 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Sale	293.12	25,045	7,341,123	28,987	Feb 10 09:52 PM
Graham Jonathan P	Officer	Feb 07 '25	Proposed Sale	292.94	25,045	7,336,682		Feb 07 03:05 PM
Grygiel Nancy A.	SVP & CCO	Feb 05 '25	Sale	304.47	1,589	483,808	7,210	Feb 06 08:54 PM
Grygiel Nancy A.	Officer	Feb 05 '25	Proposed Sale	304.47	1,589	483,800		Feb 05 12:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience